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Recent trends in gastric cancer treatment involve improving survival after curative
surgery by detecting early stage cancers. They also include improving the quality
of life after treatment by reducing the extent of surgery.
1-5 To improve quality of
life, various modifications such as endoscopic submucosal dissection and partial
gastrectomy with limited lymphadenectomy have been applied for gastric cancer
treatments that are consistent with tumor biology.
4-8 These minimally invasive
treatments for gastric cancers have received considerable attention for their better
post-treatment outcomes compared with conventional radical surgery such as
gastrectomy with extended lymphadenectomy.
9,10
The general assumption behind adopting limited lymphadenectomy for early
gastric cancer is that regional or systemic lymphadenectomy is appropriate for
clinically suspicious or pathologically proven metastases to regional lymph
nodes.
11 Thus, when there is no possibility of metastases to regional lymph nodes,
surgery without lymphadenectomy or with limited lymphadenectomy should be
sufficient for selected patients.
12
The hypothesis of the sentinel lymph node (SLN) methodology is that a metas-
tasis in the SLN could indicate metastases in other lymph nodes. In contrast, a
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Purpose: Preoperative identification of the sentinel lymph node (SLN) in gastric cancer (GC) patients may have
great advantages for the minimally invasive treatment. This study was performed to evaluate the possibility of
preoperative SLN detection using CT lymphography. Materials and Methods: Fourteen patients with early GC
were enrolled. CT images were obtained before and at 1, 3, and 5 minutes after endoscopic submucosal peritumoral
injection of 2 mL iopamidol. For patients with clearly identified SLNs, to make comparisons with the CT
lymphography results, intraoperative SLN detection was performed using subserosally injected Indocyanine green
(ICG) lymphography and ex vivo ICG and iopamidol lymphography using mammography was also performed.
Results: CT lymphography clearly visualized draining lymphatics and SLNs in 4 (28.6%) out of 14 patients. All
clearly visualized SLNs (one to three SLNs per patient) under preoperative imaging were detected in the same
location by intraoperative ICG lymphography and ex vivo ICG and iopamidol lymphography using mammo-
graphy. All preoperative SLN detections were observed with the primary tumors in the lower third of the stomach.
Conclusion: Although our study demonstrated a SLN detection rate of less than 30%, CT lymphography with
radio-contrast showed potential as a method of preoperative SLN detection for GC.
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negative SLN means the rest of the lymph nodes are tumor-
free. In patients with negative SLNs, lymphadenectomy
may be unnecessary for certain tumor types.
13,14  Therefore,
adopting the SLN concept is appropriate to reduce the
extent of lymphadenectomy in gastric cancer, just as with
solid tumors such as breast cancer and melanoma.
15
However, there are still many problems with the current
methods of SLN detection using vital dyes and/or radioac-
tive tracers during surgery.
15 Identifying SLNs in gastric
cancer patients with a preoperative study can greatly bene-
fit surgeons and patients. However, no reliable method for
preoperatively detecting the SLN in gastric cancer has
been established. Thus, the purpose of this study was to
evaluate the possibility of preoperative SLN detection
using CT lymphography.
Patients 
Fourteen patients with early gastric cancer were endosco-
pically injected with radio-contrast and were examined
with a CT scan for the purpose of SLN detection the day
prior to surgery. Informed consent was obtained from all
patients prior to examination and surgery, in accordance
with the protocol approved by the ethical committee at our
institution. The Institutional Review Board of our institu-
tion approved this study. The patient selection criteria for
the study were as follows: 1) patients with biopsy-proven
adenocarcinomas diagnosed as having early gastric cancer
by upper endoscopy with endoscopic ultrasonography and
2) no history of drug allergy. Demographic and pathologic
characteristics of the patients enrolled are shown in Table 1.  
Procedures for imaging sentinel lymph nodes
CT lymphography with endoscopic injection of radio-
contrast (Fig. 1) 
The day before the surgery, just before endoscopic injec-
tion of radio-contrast, precontrast CT images from the
diaphragmatic dome to the level of the iliac crest were
obtained while patients were in the supine position by
using a multisection CT scanner (16-channel multi-detec-
tor row CT) (Sensation 16, Siemens Medical Solutions,
Forchheim, Germany). Upper endoscopy was performed
by an attending gastroenterologist, who has 4-years experi-
ence of performing upper endoscopy as a specialist, at the
CT scanning table because CT images had to be taken
within a short period of time after the contrast injection
(Fig. 1A). End-viewing fiberoptic panendoscopes (GIF-
Q260, GIF-H260; Olympus, Tokyo, Japan) were used
after intravenously administering 5 mg of midazolam to
the patient (Taro Pharmaceutical International, Yakum,
Israel) using standard practices. Endoscopic injection of
radio-contrast was performed using a puncture needle
which was introduced endoscopically. A total of 2 mL of
MATERIALS AND METHODS
Table 1.Clinicopathologic Characteristics of the Enrolled Patients
Case
Age Sex
Gross type
Location
Size
Histology pT pN
SLN SLN No  of  No  of LND 
No of tumor* of tumor detection location* SLNs RLNs Extent*
1 48 F IIc U PW 35 mm SRC M + Failure - 45   D2
2 57 F III M LC 40 mm AMD PM - Failure - 34 D2
3 31 F IIc L PW 12 mm SRC M - Success #6 1 48 D2
4 70 M IIc + IIb L LC 15 mm AWD M - Failure - 21 D1 + beta
5 62 M IIb L LC 45 mm AWD M - Success #3, #4 3 28 D2
6 38 F IIb + III L PW 30 mm SRC SM - Failure - 40 D2
7 45 M IIa + IIb L LC 10 mm APD M - Success #3 2 24 D1 + beta
8 61 M IIc L PW 25  mm AMD M - Failure - 46 D2
9 70 F IIb + IIc L GC 30 mm AWD M - Success #6 2 29 D2
10 67 M IIc L PW 20 mm AWD M - Failure - 42 D2
11 64 M IIc L GC 9 mm APD M - Failure - 35 D1 + beta
12 70 F IIc L LC 30 mm APD SM - Failure - 16 D2
13 48 M IIc + III L PW 15 mm SRC SM - Failure - 40 D2
14 62 M IIb U LC 20 mm AMD M - Failure - 55 D2
pT, pathological depth of tumor invasion, pN, pathological nodal status; SLN, sentinel lymph node; RLN, retrieved lymph node; LND: lymph node dissection; F, 
female; M, male; U, upper third; M, middle third; L, lower third; PW, posterior wall; LC, lesser curvature; GC, greater curvature; SRC, signet ring cell carcinoma;
AWD, adenocarcinoma well-differentiated; AMD, adenocarcinoma moderately-differentiated; APD, adenocarcinoma poorly-differentiated; M, mucosa; SM,
submucosa; PM, proper muscle. 
*Based on Japanese Classification of Gastric Carcinoma Classification.
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undiluted iopamidol (Iopamiron 370; Bayer-Schering,
Berlin, Germany) was gently administered into the submu-
cosa at four points adjacent to the tumor (with a 0.5 mL
dose at each point) (Fig. 1B). CT lymphography was taken
before and at 1, 3, and 5 minutes after contrast injection
with the following parameters: 120 kV; 350 mA; detector
collimation; 0.75 mm, matrix, 512×512; and reconstruc-
tion thickness, 1 mm (Fig. 1C). A radiologist, who has 8-
years experience of specialty in hollow viscus radiology,
placed regions of interest in each SLN using a CT worksta-
tion for estimating the degree of contrast enhancement.
Lymph node enhancement was judged to be positive if the
attenuation of a node on post-contrast images was increas-
ed by more than 30 Hounsfield units compared with the
attenuation of the node on pre-contrast images.
16 
Intraoperative and ex vivo SLN detection (Fig. 2)
Intraoperative lymphatic mapping using a vital dye and
SLN biopsy was performed only for those patients who
showed clear visualization of SLNs in CT lymphography.
Immediately after laparotomy, 2 mL of 0.63% indocyanine
green solution (ICG, Diagnogreen; Dai-Ichi Pharm Co.
Ltd., Tokyo, Japan) was injected into the subserosal layer
at four points adjacent to the tumor. All lymph nodes that
were stained green within 5 minutes after the dye injection
were regarded as SLNs. 
After gastrectomy with en bloc extended lymph node
dissection, ex vivo detection of the SLN was performed.
To match the CT lymphography results with introperative
SLN detection, an X-ray mammography of the specimen
was obtained after peritumoral submucosal injection of a
mixture of iopamidol and ICG for ex vivo detection of the
SLN at a mammography suite. All lymph nodes that were
stained green were regarded as SLNs, and we examined
whether they were enhanced by using the mammography. 
Pathologic exam
Immediately after iopamidol lymphography using mam-
mography, SLNs were picked up and the other regional
lymph node groups were removed from the stomach. All
lymph nodes were grouped according to the Japanese
classification of Gastric Carcinoma.
17 For all lymph nodes
dissected, including SLNs, one section from each paraffin-
embedded specimen was stained conventionally with
hematoxylin and eosin and examined by pathologists. 
CT lymphography clearly visualized draining lymphatics
and SLNs within 5 minutes after contrast injection in 4
(28.6%) out of 14 patients (cases 3, 5, 7, and 9). CT lym-
phography failed to visualize the draining lymphatics and
reliable SLNs in the ten remaining patients. The results are
summarized in Table 1 and Fig. 3. 
In all four patients with successful preoperative detec-
RESULTS
Fig. 1. CT lymphography. (A) Upper endoscopy for peritumoral injection of iopamidol at the CT scanning table. (B) Successful preitumoral submucosal injection of
iopamidol showing swelling of the lesion. (C) Axial CT image after iopamidol injection (long arrow: SLN, Short arrow: draining lymphatic). SLN, Sentinel lymph node.
ABC
ABCD
Fig. 2. Intraoperative and ex vivo SLN detection. (A) Three-dimensional volume rendering image of CT lymphography. Contrast enhanced SLN (long arrow) and
draining lymphatics (short arrow) well-visualized at station #6. Dense iopamidol uptake at the peritumoral area is seen (arrow head) with a related beam hardening
artifact. (B) Intraoperative SLN navigation with surserosal injection of ICG. A green colored SLN (long arrow) and a draining lymphatic (short arrow) are well identified
with subserosal site injection (arrow head). (C) Ex vivo sentinel lymph node navigation using subserosal injection of ICG. SLN with ICG uptake (long arrow) and
peritumoral area (arrow head) are stained green. (D) X-ray mammography. Magnified view shows the draining lymphatic vessel (short arrow) by peritumoral iopamidol
injection (arrowhead).  SLN, Short arrow: draining lymphatic). SLN, Sentinel lymph node; ICG, Indoc yanine green.Woo Jin Hyung, et al.
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tion of the SLN, the primary tumor was located in the
lower third of the stomach. The stations of SLN detected
were in the perigastric location. The SLN was identified in
a single lymph node station in three patients: in the infra-
pyloric area (station #6) for tumors located at the posterior
wall of the antrum and at the greater curvature of the lower
body (cases 3 and 9), and at the lesser curvature area of the
lower body (station #3) for a lesion located at the lesser
curvature of the lower body (case 7). For another patient
with a lesion located in the lesser curvature side of the lower
body (case 5), SLNs were located at lymph nodes along
lesser and greater curvature regions (stations #3 and #4). 
Among the four patients who underwent successful
preoperative imaging of the SLN, all SLNs (one to three
nodes per patient) were found intraoperatively by submu-
cosal injection of ICG at the same location under CT
lymphography guidance. And iopamidol lymphography
using mammography also detected the same SLNs ex vivo.
Ex vivo iopamidol lymphography with mammography
clearly visualized the lymphatic flow as ICG (Fig. 2). No
lymph node metastases were identified in SLNs as well as
non-SLNs upon pathologic examination using hemato-
xylin-eosin staining in all four patients. 
In the remaining ten patients, CT lymphography failed
to visualize the draining lymphatics connected to the SLNs.
One patient showed two metastatic lymph nodes in station
#3 while the other nine patients showed no lymph node
metastasis. 
While tumors were located in the lower body in all four
patients who underwent successful preoperative imaging
of SLNs, preoperative detection of the SLN using CT lym-
phography was not successful in patients with a primary
lesion in the mid or upper third of the stomach or with an
ulcer in the primary lesion (Fig. 3) (Table 1). 
In this study, we found that SLN detection using CT lym-
phography showed potential as a useful tool in the context
of a minimally invasive treatment for early gastric cancer,
although a less than 30% SLN detection rate was demon-
strated. 
Although there is not enough evidence of application of
sentinel node concept for gastric cancer patients, recent
studies have shown that sentinel lymph node navigation
during gastrectomy can be an alternative for conventional
extended gastrectomy for gastric cancer patients, provided
that appropriate indications are employed.
13-15,19 Currently,
SLN detection is performed during an operation using vari-
ous types of vital dye, radioisotopes, or dual methods.
14,18,19
Vital dyes as tracers for SLN detection have the disadvan-
tages of hypersensitivity, time limitations for detecting
SLN, and difficulty in detecting deep-seated SLN.
15 When
dyes are used for SLN detection in gastric cancer, it is
difficult to conduct this procedure during laparoscopy, and
intraoperative endoscopy is needed for dye injection.
20
Radioisotope also has problems associated with radiation
hazard, the need for a gamma detector, imprecise lymphos-
cintigraphy information, and a shine-through effect.
15
Furthermore, these intraoperative procedures for detecting
SLNs make for a longer operation. Theoretically, SLN
detection using CT lymphography has the advantages of
avoiding radiation hazard and it allows medical personnel -
including operating surgeons - to obtain accurate anatomical
information, thereby eliminating additional operative pro-
cedure and reducing the operative time,
21-23 although addi-
tional radiation exposure during CT lymphography does
occur because CT lymphography is additionally performed
after the routine preoperative CT for staging. 
Although there is controversy regarding SLN detection
after excisional biopsy for breast cancer and melanoma,
the previous biopsy does not affect the accuracy of SLN
detection. However, SLN detection after a wide excision
of the primary lesion may decrease the accuracy of SLN
detection because the destruction of lymphatic channels by
previous surgical procedures may change the original lym-
phatic drainage pattern.
24 The lymphatic drainage of the
stomach is multidirectional.
25 Usually, endoscopic submu-
cosal dissection ESD is performed with a circumferential
margin of at least 1 cm, if possible.
26 Due to the possibility
of different lymphatic drainage directions within different
areas of the stomach, SLN navigation after ESD may not
Fig. 3. Results of CT lymphography with iopamidol according to the location of
the primary lesion. Success refers to the primary lesion that SLNs were seen on
CT lymphography. Failure refers to the primary lesion that SLNs were not seen
on CT lymphography. *indicates primary lesions with ulcers. SLN, Sentinel
lymph node.
DISCUSSIONdetect the SLN of the primary lesion already resected by
ESD, although Abe, et al.
27 have reported successful appli-
cation of laparoscopic SLN navigation after ESD for five
patients. Therefore, if pretreatment SLN detection using
CT lymphography were to become possible, SLN naviga-
tion could be easily applied to the patients laparoscopically
after endoscopic submucosal dissection. Because a CT
scan is mandatory before ESD for every patient, SLN
basin dissection may be possible using information ob-
tained from CT lymphography.
20
However, we identified SLNs only 30% with preopera-
tive CT lymphography with iopamidol. The low detection
rate of CT lymphography using iopamidol may be explain-
ed as follows: 1) The water soluble characteristics of iopa-
midol may affect rapid wash-out of interstitially injected
iopamidol after diffusion into the lymphatic stream, thus
causing the detection rate to depend on the timing of the
CT scans in respect of vital dyes; 2) The use of non-diluted
iopamidol, due to the dependence of the amount of con-
trast drained to the lymph node on the injected iodine dose,
causes difficulty in discriminating an SLN adjacent to a
primary lesion from the primary lesion itself because of
beam-hardening artifacts in the context of the shine-
through effect of the isotope method
28; and 3) Organ-
specific characteristics of the stomach in terms of SLN
detection may influence the low detection rate unlike the
100% detection rate of esophageal cancer SLN detection
by CT lymphography.
21 In addition, the low detection rate
might be affected by tumor locations. As shown in this
study, detection of SLNs by CT lymphography was suc-
cessful only in patients with primary lesions in the lower
stomach. 
The peak nodal CT attenuation after interstitial contrast
injection is known to be 1 minute.
21 This short optimal
window for CT scanning may be related to the low detec-
tion rate of SLNs in this study, although we performed
endoscopic injection of iopamidol at the CT table. There-
fore, development of new radio-contrast that has the cha-
racteristics of a radioisotope and uptake by lymph nodes
over a wide CT scanning time-window may be a solution
to enabling a higher detection rate. Optimization of CT
parameters to decrease beam hardening artifacts may be
another approach to increasing the detection rate. Other
technical difficulties of CT lymphography are 1) the CT
room is a difficult environment for endoscopic procedure,
2) the endoscopist did not reach the learning curve at that
time, and 3) technical difficulty to adjust the injection har-
mony with CT scanning.
Not only the technical aspects of CT lymphography, but
also the tumor characteristics, such as the anatomical loca-
tion and the presence of ulcers, are important factors in
achieving a higher rate of SLN detection in gastric cancer.
The detection rate of SLNs is decreased in tumors located
in the mid or upper third,
29 and SLN mapping is not useful
when there is altered or destroyed lymphatic drainage.
30
Our failure to detect SLNs in patients with a primary lesion
in the mid or upper third of the stomach or with an ulcer in
the primary lesion may be related to their tumor charac-
teristics. Therefore, proper selection criteria based on tumor
characteristics may be necessary for the application of SLN
navigation in gastric cancer patients. 
In this study, there was a patient with lymph node meta-
stasis but CT lymphography failed in that patient. Because
intraoperative SLN detection using ICG and ex vivo iopa-
midol lymphography using mammography were performed
only for those patients who showed clear visualization of
SLNs in CT lymphography, we cannot explain the accurate
reason of non-visualization of lymph node by CT-lympho-
graphy which had been identified by histopathologic
examination. However, non-visualization of the metastatic
lymph node by CT lymphography in our study does not
mean than CT lymphography is not a reliable method. It
may come from a low detection rate of iopamidol CT lym-
phography.
This study examined the SLN intraoperatively only for
those patients who showed clear visualization of SLNs in
CT lymphography. Thus, we cannot fully evaluate the rea-
sons of SLN detection failure in ten patients. Furthermore,
all four patients with successfully detected SLNs showed
no lymph node metastasis. Because of node negativity in
all SLNs detected, it was impossible to evaluate positive
predictive value, false negative rate, etc. Therefore, for the
thorough and comprehensive evaluation of the role of CT
lymphography for SLN detection in gastric cancer patients,
complete SLN examinations of the patients either with or
without SLNs visualized in CT lymphography and enough
number of patients either with or without lymph node
metastasis should be enrolled to evaluate the detection rate,
accuracy, false negative, and so on. To show that nodes
which are marked by CT-lymphography represent sentinel
nodes, several early gastric cancers with lymph node meta-
stasis should be included in cases with SLN detected by
CT lymphography. However, as shown in Fig. 2, among
the four patients who underwent successful preoperative
imaging of the SLN, all SLNs were found intraoperatively
by submucosal injection of ICG at the same location under
CT lymphography guidance. And iopamidol lymphogra-
phy using mammography also detected the same SLNs ex
vivo. Ex vivo iopamidol lymphography with mammogra-
phy clearly visualized the lymphatic flow as ICG (Fig. 2).
Thus, we can confirm that SLNs detected by CT-lympho-
graphy is SLNs detected by dye method using ICG,
although it is not proved that SLN detected CT lymphogra-
phy can actually concord with metastatic lymph node.
Preoperative Sentinel Node Imaging
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CT lymphography in gastric cancer patients, we cannot
validate the clinical feasibility of CT lymphography. We
only found potential possibility of SLN detection by CT
lymphography with a low detection rate. To show the clini-
cal feasibility and to provide a clinical significance of SLN
detection using CT lymphography, the low SLN detection
rate associated with CT lymphography should be solved. If
over 90% of SLN detection rate by CT lymphography is
achieved by developing better protocols and contrast sys-
tem, evaluation of the clinical feasibility of CT lymphogra-
phy for patients with gastric cancer and the determination
of the extent of lymph node detection can be reached.
Although this study is a pilot study to identify the possibility
of preoperative SLN detection using CT lymphography
with a very small number of patients, we found potential of
CT lymphography for preoperative SLN detection. And to
our knowledge, this is the first study of preoperative SLN
detection using CT lymphography in gastric cancer patients. 
In conclusion, from the results of this study, CT lympho-
graphy with radio-contrast showed potential as a method
of preoperative SLN detection for GC although the SLN
detection rate was less than 30%. For better results, the
development of a radio-contrast that allows a wide time-
window for CT scanning and complementary methods for
reducing the beam hardening effect are needed.
This work supported by a Korean Research Foundation
Grant (KRF-2006-E00316).
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